MUHC in the Media - September 14, 2026
Major spinal surgery for five-year-old girl
At just five years old, Molly had to undergo major surgery at the Montreal Children’s Hospital (MCH) due to serious problems with her spine and spinal cord. The surgery, performed by MCH neurosurgeon Dr. Roy Dudley, relieved pressure on her spinal cord. Two weeks later, Molly was able to start kindergarten. Her scoliosis is now expected to gradually improve, which could spare her from needing another surgery. Journal de Montréal
The Montreal Children's Hopsital becomes the first pediatric hospital in Quebec to offer bariatric surgery to adolescents
The Montreal Children's Hospital (MCH) has become the first pediatric hospital in Quebec and the second in Canada to offer bariatric surgery in-house to adolescents through its multidisciplinary clinic dedicated to the management of severe obesity.
Previously, patients were referred to adult centres for surgery and postoperative care. Dr. Etienne St-Louis, a surgeon at the MCH, is the only pediatric surgeon in Canada with subspecialty training in bariatric surgery. At other institutions, the procedure is performed by adult surgeons.
The first surgery at the MCH took place on May 19 and was successful. Radio-Canada
Healthier fats linked to longer survival after prostate cancer diagnosis
A study co-led by Prof. David P. Labbé, Ph.D., at The Institute and by colleagues at the Harvard T.H. Chan School of Public Health found that replacing saturated and animal fats with unsaturated and plant-based fats was associated with a lower risk of death among men with nonmetastatic prostate cancer. The results were published in JAMA Network Open. Radio-Canada, Le Soleil, La Presse
Researchers create a beating “mini-heart” from a patient’s blood cells
Dr. Renzo Cecere, a scientist at The Institute, and Ali Mousavi, PhD, a postdoctoral fellow in his lab at The Institute, have created, with their colleagues, a three-dimensional, beating heart-on-a-chip, or “mini-heart,” using blood cells from a patient with dilated cardiomyopathy (DCM), a leading cause of heart transplantation. CityNews, La Presse
MUHC at the forefront of mRNA research in cancer treatment
Dr. Ramy Saleh and Dr. Jonathan Spicer are leading international clinical trials at the MUHC exploring the potential of personalized mRNA vaccines to treat cancer. From lung cancer to bladder cancer, these innovative trials are bringing new approaches to patients while advancing research in personalized cancer care. Noovo Info